Related Experiment Videos
New methods for identifying "at risk" patients for osteoporosis
1Department of Clinical Chemistry, Glostrup Hospital, Denmark.
Clinical Rheumatology
|June 1, 1989
Summary
Early postmenopausal women at high risk for osteoporosis can be identified using simple biochemical screening. This allows for early intervention with hormone replacement therapy to prevent fractures.
Area of Science:
- Endocrinology
- Osteoporosis Research
- Geriatric Medicine
Background:
- Menopause is associated with accelerated bone loss.
- Osteoporotic fractures pose a significant health risk to postmenopausal women.
- Early identification of women at risk is crucial for preventative strategies.
Purpose of the Study:
- To evaluate a simple biochemical screening method for identifying fast bone losers in early postmenopause.
- To assess the efficacy of this screening in predicting future fracture risk.
- To enable timely initiation of prophylactic treatment.
Main Methods:
- Photon absorptiometry was used to measure forearm bone mineral content (BMC) over two years in 178 early postmenopausal women.
- A sequential cut-off technique analyzed body fat mass, urinary calcium and hydroxyproline, and serum alkaline phosphatase.
- The screening procedure was validated in a separate group of 70 women.
Main Results:
- The biochemical screening correctly identified 79% of fast bone losers (bone loss >3% annually).
- It also identified 78% of slow bone losers.
- The method proved effective in a new cohort of 70 women over two years.
Conclusions:
- A simple biochemical screening approach can effectively identify early postmenopausal women at high risk of rapid bone loss.
- This early identification facilitates prompt initiation of prophylactic hormone replacement therapy.
- The findings support early intervention to mitigate the risk of osteoporotic fractures.